Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Hidden Gems: 3 Penny Stocks Flying Under the Radar.

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
Overlooked penny stocks are set to rally once the overall stock market and economy pivot to the upside - These are three winners.

3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought

By Rich Duprey, InvestorPlace Contributor
Yet just as quickly, it made a U-turn and more than doubled again over the next 18 months.

Marijuana Stocks 2023: 3 Cannabis Names You’ll Regret Not Buying Now

By Jeremy Flint, InvestorPlace Contributor
Cannabis stocks are back on the menu, but don't play them like we did in 2018 - instead, look closely for long-term potential.

Why Is Seelos Therapeutics (SEEL) Stock Down 25% Today?

By William White, InvestorPlace Writer
Seelos Therapeutics stock is falling on Thursday with heavy trading of SEEL shares after the company released results from a clinical trial.

Why Is Heart Test Laboratories (HSCS) Stock Moving Today?

By William White, InvestorPlace Writer
Heart Test Laboratories stock is rising higher on Thursday as news of a new collaboration has HSCS shares on a wild ride this morning!

Don’t Fall for These 7 Meme Stocks That Are Heading for a Crash

By Alex Sirois, InvestorPlace Contributor
Investors would do well to avoid these meme stocks as they move nearer to a crash in the third quarter.

Bullet Proof Your Portfolio: 3 Must-Have Defensive Stocks for 2023

By Rick Orford, InvestorPlace Contributor
For example, utilities, healthcare, and non-cyclical industries cushion investor portfolios because their business is a staple regardless of the economic cycle.

CGC Stock Alert: Canopy Growth Preps for the Resale of 45 MILLION Shares

By Chris MacDonald, InvestorPlace Contributor
Canopy Growth has continued its decline today, with CGC stock sinking 12% on the news that the company will be selling more shares.

3 AI Stocks That Should Be on Every Investor’s Radar This Fall

By Omor Ibne Ehsan
These pick-and-shovel AI plays are poised to deliver tremendous returns with rapid sales expansion over the coming years.

Why Is MSP Recovery (LIFW) Stock Up 100% Today?

By Chris MacDonald, InvestorPlace Contributor
Investors in MSP Recovery and LIFW stock are seeing some signs of life today, as this little-known stock surges more than 100%.

Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now

By Alex Sirois, InvestorPlace Contributor
There are always many biotech stocks to avoid and these firms are among the clearest choices currently to steer clear of.

TTOO Stock Alert: T2 Confirms FDA Clearance for Biothreat Panel

By Samuel O'Brient, InvestorPlace Reporter
T2 Biosystems is plunging today despite receiving good news from the FDA yesterday. Here's what investors should know about TTOO stock.

Betting Big: 3 Cannabis Stocks Primed for a Breakout

By Matthew Farley, InvestorPlace Contributor
Due to the indecision we're seeing now in the market, some cannabis stocks are poised to make big moves in the near future.

The 3 Most Undervalued Under-$10 Stocks to Buy in September 2023

By Tyrik Torres, InvestorPlace Contributor
Undervalued stocks are not just found in older industries; rather, many can be found in emerging spaces as well.

The Top 7 Underrated Dividend Stocks Yielding 3% or More

By Alex Sirois, InvestorPlace Contributor
Investors seeking dependable income and upside should buy these dividend stocks yielding 3% or more, the sooner the better

7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom

By Alex Sirois, InvestorPlace Contributor
Cannabis stocks re seeing renewed interest and these seven look like reasonable buys as resceduling approaches for weed.

Only Invest in Canopy Growth Stock If You’re Looking to Gamble

By David Moadel, InvestorPlace Contributor
Speculative traders may have given CGC stock a quick boost, but that doesn't mean Canopy Growth is a viable business for the long haul.

Why Is T2 Biosystems (TTOO) Stock Up 30% Today?

By Larry Ramer, InvestorPlace Contributor
TTOO stock is climbing over 30% after the Food and Drug Administration ruled that T2 Biosystems can sell its new biothreat test. 

Investor Alert: 3 Red-Hot Opportunities You Can’t Afford to Miss

By Yiannis Zourmpanos, InvestorPlace Contributor
The trio has adapted to the changing landscape and thrived in it, redefining their respective industries.
Load More Articles